- 米国企業
- OPGEN INC
OPGEN INCOPGN
時価総額
$460.6万
PER
2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2022年 12月31日 | |
Product sales | - | - | - | - | - | - | 2 |
Laboratory services | - | - | - | - | - | - | 172,633 |
Collaboration revenue | - | - | - | - | - | - | 540,798 |
Total revenue | 3 | 4 | 3 | 3 | 3 | 4 | 3 |
Product sales | - | - | - | 1 | 911,565 | 3 | - |
Laboratory services | - | - | - | 625,516 | 720,156 | 488,211 | - |
Cost of products sold | - | - | - | - | - | - | 3 |
Cost of services | - | - | - | - | - | - | 104,405 |
Research and development, net | 6 | 9 | 7 | 6 | 5 | 10 | 8 |
General and administrative | 6 | 7 | 7 | 7 | 6 | 9 | 9 |
Sales and marketing | 4 | 6 | 3 | 2 | 1 | 3 | 4 |
Impairment of right-of-use asset | - | - | - | - | 520,759 | 101,838 | - |
Impairment of intangible assets | - | - | - | - | - | 750,596 | 5 |
Goodwill impairment charge | - | - | - | - | - | - | 7 |
Total operating expenses | - | 23 | 18 | 16 | 16 | 27 | 37 |
Operating loss | -15,059,163 | -19,009,337 | -15,265,791 | -13,180,242 | -12,271,245 | -22,718,479 | -34,567,121 |
Gain on extinguishment of debt | - | - | - | - | - | 884,970 | - |
Interest and other income, net | - | -5,967 | -87,255 | 5,384 | 9,859 | 105,627 | 46,935 |
Interest expense | 2 | 143,347 | 233,505 | 191,195 | 187,549 | 3 | 3 |
Foreign currency transaction gains | - | -8,102 | 23,179 | -10,431 | 2,410 | -1,468,855 | 379,622 |
Change in fair value of derivative financial instruments | - | - | 144,064 | 8,386 | 67 | 517,680 | 113,741 |
Total other expense | -2,422,005 | -157,416 | -153,517 | -187,856 | -175,213 | -3,359,962 | -2,716,112 |
Loss before income taxes | -17,481,168 | -19,166,753 | -15,419,308 | -13,368,098 | -12,446,458 | -26,078,441 | -37,283,233 |
Provision for income taxes | -129,095 | - | - | - | - | 132,403 | - |
Net loss | -17,352,073 | -19,166,753 | -15,419,308 | -13,368,098 | -12,446,458 | -26,210,844 | -37,283,233 |
Deemed dividend on beneficial conversion feature | - | 332,550 | - | - | - | - | - |
Net loss available to common stockholders | -17,595,835 | -19,499,303 | -15,419,308 | - | - | - | -37,283,233 |
Basic and diluted net loss per share attributable to common stockholders (in Dollars per share) | - | - | - | - | - | - | -15.27 |
Net loss | -17,352,073 | -19,166,753 | -15,419,308 | -13,368,098 | -12,446,458 | -26,210,844 | -37,283,233 |
Other comprehensive loss - foreign currency translation | -1,059 | 7,235 | -32,076 | 12,807 | -4,222 | 3 | -1,381,466 |
Comprehensive loss | -17,353,132 | -19,159,518 | -15,451,384 | -13,355,291 | -12,450,680 | -23,646,347 | -38,664,699 |